HY-119033-50mg
|
MedChemexpress LLC
|
MGL-IN-1 [CAS 1881244-28-5]
|
|
COVID-19-immunoregulation
|
|
HY-119033-1mL
|
MedChemexpress LLC
|
MGL-IN-1 [CAS 1881244-28-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-130457-100mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
HY-130457-250mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
HY-130457-50mg
|
MedChemexpress LLC
|
m-PEG4-Ms [CAS 130955-37-2]
|
|
Cancer-programmed cell death
|
|
D679195-10mg
|
Toronto Research Chemicals
|
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS] [CAS 666174-80-7]
|
|
|
|
D679195-50mg
|
Toronto Research Chemicals
|
2,5-Dihydroxybenzoic Acid Butylamine Salt [Matrix for MALDI-TOF/MS] [CAS 666174-80-7]
|
|
|
|